NEW
YORK, July 17, 2024 /PRNewswire/ -- The global
cancer registry software market size is estimated to grow by
USD 97.1 million from 2024-2028,
according to Technavio. The market is estimated to grow at a
CAGR of 12.75% during the forecast
period. Growing prevalence of cancer cases is driving
market growth, with a trend towards increasing clinical research
for oncology. However, data privacy and security concerns poses a
challenge. Key market players include CDC, Conduent Inc., Elekta
AB, ERS Inc., Inspirata Inc., International Association of Cancer
Registries, International Business Machines Corp., McKesson Corp.,
NeuralFrame Inc., OMH HealthEdge Holdings LLC, Onco Inc., Ordinal
Data Inc., Redsson Ltd., Siemens AG, and University of Utah Health.
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
End-user (Government
and third party, Pharma
biotech and medical device companies, Hospitals
and medical practice, Private payers, and
Research institutes), Type (Stand-alone software
and Integrated software), and Geography (North
America, Europe, Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
CDC, Conduent Inc.,
Elekta AB, ERS Inc.,
Inspirata Inc., International Association of Cancer
Registries, International Business Machines Corp.,
McKesson Corp., NeuralFrame Inc., OMH
HealthEdge Holdings LLC, Onco Inc., Ordinal Data
Inc., Redsson Ltd., Siemens AG, and University of
Utah Health
|
Key Market Trends Fueling Growth
Pharmaceutical and biopharmaceutical companies, along with
research institutes, prioritize clinical trials to discover new
cancer treatment methods. These trials enable medical professionals
to assess treatment efficacy and identify potential diagnoses.
Randomized clinical trials (RCTs) facilitate comparing care
approaches and treatment options, supporting informed clinical
decisions. Population-based and hospital-based cancer registries
offer access to comprehensive data for researchers and healthcare
providers. This data is crucial for recruiting large patient groups
and analyzing causes and cures during clinical research. Advanced
cancer registry software enhances data quality, improving clinical
research and healthcare evaluation. Consequently, the growth of the
cancer registry software market is anticipated during the forecast
period.
The Cancer Registry Software Market is witnessing significant
growth due to the increasing incidence of cancer and the need for
effective population health management. Software solutions are
essential for tracking cancer-specific outcomes, including cancer
deaths, prevalence, and staging. These systems help medical
professionals capture and exchange health information data for
coordinated care and chronic disease management. Cancer Registry
Software is vital for hospitals and healthcare organizations to
meet healthcare quality goals and adopt Electronic Health Records
(EHR). Vendors offer customized solutions for specific areas like
lung cancer, developmental disabilities, and cognitive capacities.
The software facilitates evidence-based medicine through
observational studies, data capture systems, and disease
registries. Cancer Registry Software also addresses concerns like
medical identity theft and supports cancer treatment through chemo,
surgery, and supportive therapies. By providing cancer diagnostics
and treatment information, these systems contribute to the adoption
of evidence-based therapeutics and improved patient care. The Lung
Cancer Foundation and other healthcare organizations can leverage
these tools to improve healthcare outcomes and advance research in
the field.
Discover 360° analysis of this market. For
complete information, schedule your consultation- Book
Here!
Market Challenges
- Cancer registry software is essential for collecting and
maintaining patient demographic information related to cancer,
including details on tumor characteristics, stage of disease,
treatment, and outcome. Confidentiality is paramount in handling
this sensitive data, as disclosure can cause psychological,
emotional, and financial harm. Regulatory bodies and organizations
are implementing new guidelines and laws to ensure data protection,
such as the North American Association for Central Cancer
Registries (NAACCR) and the Health Insurance Portability and
Accountability Act (HIPAA). However, challenges persist, such as
the use of cloud and computer systems for storing and transmitting
data, which may result in data alteration or loss. Additionally,
evolving technology and increasing cyberattacks in the healthcare
industry pose significant security risks. These challenges may
hinder the growth of the cancer registry software market during the
forecast period. To address these challenges, it is crucial to
adhere to established guidelines, invest in secure technology
tools, and ensure proper network connectivity. For instance, the
NAACCR provides standard guidelines for securing patient data
against unauthorized access and release, while the HIPAA and HHS
offer federal standards for protecting customer health data. In
developing countries, guidance on planning and developing
population-based cancer registration is available, but awareness of
new laws and guidelines remains a concern. In conclusion, while
cancer registry software plays a vital role in managing cancer
data, maintaining confidentiality, and adhering to regulatory
requirements is crucial to mitigate risks and ensure the effective
use of this technology. By addressing challenges related to data
security, network connectivity, and regulatory compliance, the
cancer registry software market can continue to grow and provide
valuable insights for cancer research and patient care.
- The Cancer Registry Software market is witnessing significant
growth due to the rising prevalence of cancer and the increasing
adoption of electronic health records (EHR). The market faces
challenges in integrating data from various cancer treatments,
including chemotherapy, surgery, and supportive therapies, into
cancer registries. The need for evidence-based medicine and
therapeutics requires seamless data integration and
interoperability between healthcare systems. Medical professionals
and patients benefit from cancer registries for disease staging,
treatment planning, and cancer screenings. Security is a major
concern, with data security and security protocols essential for
protecting sensitive patient information. The market includes
standalone and integrated software solutions for cancer reporting,
patient care management, and medical research. The changing
landscape of cancer care involves collaboration between hospitals,
medical practices, pharmaceutical, biotech, and medical device
companies, oncology departments, and research institutes. Cancer
registries play a crucial role in improving cancer care and
reducing healthcare costs.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This cancer registry software market report extensively covers
market segmentation by
- End-user
- 1.1 Government and third party
- 1.2 Pharma biotech and medical device companies
- 1.3 Hospitals and medical practice
- 1.4 Private payers
- 1.5 Research institutes
- Type
- 2.1 Stand-alone software
- 2.2 Integrated software
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Government and third party- Cancer
registry software is essential for government hospitals and
third-party agencies to effectively manage and analyze data related
to cancer cases. These solutions enable monitoring and tracking of
cancer incidence, prevalence, and mortality rates, providing
valuable information for public health planning, resource
allocation, and policy development. By identifying trends and
patterns, governments and third-party agencies can target high-risk
populations and geographic disparities, as well as emerging cancer
types. Additionally, cancer registry software helps improve the
quality of cancer care by evaluating adherence to clinical
guidelines, benchmarking outcomes, and identifying variations in
treatment practices. This data-driven approach will fuel the
expansion of the government and third-party segments in the global
cancer registry software market during the forecast period.
For more information on market segmentation with geographical
analysis including forecast (2024-2028) and historic data (2018 -
2022) - Download a Sample Report
Learn and explore more about Technavio's in-depth research
reports
The global head and neck cancer treatment market is driven by
advancements in targeted therapies and surgical techniques. Key
players focus on personalized medicine and innovative drug
development to improve patient outcomes and survival rates.
The global cancer biologics market continues to expand with the
rise in biopharmaceutical research. Biologics offer targeted
therapies with reduced side effects, driving adoption among
oncologists worldwide. Emerging biotech firms and established
pharmaceutical companies compete to introduce novel biologic
treatments.
The global liquid biopsy market is poised for rapid growth,
revolutionizing cancer diagnostics. Non-invasive detection methods
using circulating tumor DNA and RNA enable early cancer detection
and treatment monitoring. Innovations in sequencing technologies
and biomarker research drive market expansion, offering promise for
personalized oncology care.
Research Analysis
The Cancer Registry Software Market has witnessed significant
growth due to the increasing incidence of cancer worldwide.
According to the World Health Organization, there were an estimated
19.3 million new cases and 9.9 million deaths from cancer in 2020.
With the adoption of Electronic Health Records (EHR) and the push
towards evidence-based medicine, there is a growing demand for
cancer registry software solutions. These systems help medical
professionals track cancer treatment, including chemotherapy,
surgery, and supportive treatments, and collect data on
cancer-specific outcomes. The software also aids in the management
of diagnostic data and post-endoscopic resection records. The
market growth is further driven by the need to reduce healthcare
costs and improve patient care. A guidance document issued by the
National Cancer Institute outlines the importance of maintaining
accurate and complete cancer data for research and public health
purposes. Patients and medical professionals alike benefit from the
use of cancer registry software, as it facilitates better
communication and coordination among healthcare providers and
enables more effective treatment plans.
Market Research Overview
The Cancer Registry Software market is witnessing significant
growth due to the increasing prevalence of cancer and the adoption
of electronic health records (EHR) in healthcare systems. The
software solutions enable seamless data integration and
interoperability, allowing medical professionals to access
evidence-based medicine and make informed decisions for cancer
treatment. These systems store data on cancer cases, including
disease staging, treatment modalities such as chemo, surgery, and
supportive therapies, and cancer screenings. Cancer registries play
a crucial role in cancer reporting, patient care management,
medical research, and clinical studies, leading to improved cancer
care and cancer-specific outcomes. The software caters to various
types of cancer and supports hospital workflows, coordinated care,
and chronic disease management. The changing landscape of
healthcare costs, population health management, health information
exchange, and disease registries necessitates the use of cancer
registry software. However, concerns around data security and
security protocols are essential considerations for software
vendors. The market includes standalone and integrated software
solutions used by research institutes, hospitals, medical
practices, pharmaceutical, biotech, and medical device companies,
oncology departments, clinics, and other healthcare entities. The
software supports cancer patients throughout the course of their
disease, from diagnosis to treatment and beyond. Additionally, the
software facilitates healthcare quality goals, hospital workflows,
and observational studies, allowing for better data capture and
management. Despite these benefits, challenges such as medical
identity theft and cognitive capacities for using complex software
remain.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- End-user
-
- Government And Third Party
- Pharma Biotech And Medical Device Companies
- Hospitals And Medical Practice
- Private Payers
- Research Institutes
- Type
-
- Stand-alone Software
- Integrated Software
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cancer-registry-software-market-size-is-set-to-grow-by-usd-97-1-million-from-2024-2028--growing-prevalence-of-cancer-cases-to-boost-the-market-growth-technavio-302198405.html
SOURCE Technavio